Collegium Pharmaceutical (COLL) Change in Acquisitions & Divestments (2023 - 2026)

Collegium Pharmaceutical has reported Change in Acquisitions & Divestments for 4 years, with the latest figure at $131.8 million in Q2 2026.

• On a quarterly basis, Change in Acquisitions & Divestments rose 857.77% year-over-year to $131.8 million in Q2 2026; TTM through Jun 2026 was $186.2 million, a 144.49% increase from a year earlier, with the FY2025 full-year figure at $65.2 million, down 29.62% from the prior year.
• Change in Acquisitions & Divestments was $131.8 million for Q2 2026 at Collegium Pharmaceutical, up from $20.0 million in the prior quarter.
• The five-year high for Change in Acquisitions & Divestments was $131.8 million in Q2 2026, with the low at $13.8 million in Q2 2025.
• Average Change in Acquisitions & Divestments over 4 years is $29.6 million, with a median of $19.8 million recorded in 2025.
• The sharpest annual moves came in 2025 and 2026: Change in Acquisitions & Divestments slumped 50.49% in 2025, then soared 857.77% in 2026.
• Over 4 years, Change in Acquisitions & Divestments stood at $16.0 million in 2023, then retreated by 0.15% to $16.0 million in 2024, then rose by 24.2% to $19.8 million in 2025, then surged by 564.24% to $131.8 million in 2026.
• The last three Change in Acquisitions & Divestments figures came in at $131.8 million (Q2 2026), $20.0 million (Q1 2026), and $19.8 million (Q4 2025), per Business Quant data.